Clinica Chimica Acta, Год журнала: 2024, Номер 566, С. 120039 - 120039
Опубликована: Ноя. 15, 2024
Язык: Английский
Clinica Chimica Acta, Год журнала: 2024, Номер 566, С. 120039 - 120039
Опубликована: Ноя. 15, 2024
Язык: Английский
Inorganic Chemistry Communications, Год журнала: 2024, Номер unknown, С. 113575 - 113575
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
3Inorganic Chemistry Communications, Год журнала: 2025, Номер unknown, С. 114449 - 114449
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0ACS Sensors, Год журнала: 2025, Номер unknown
Опубликована: Апрель 22, 2025
Point-of-care testing (POCT) devices are revolutionizing health monitoring by enabling rapid and accessible outside conventional laboratory environments. However, achieving laboratory-level accuracy in these portable continues to pose a significant challenge. This study introduces e-Patram, an innovative paper-based POCT sensor specifically designed for the precise efficient of dopamine (DA) urine, critical biomarker neurological health. Regular DA is essential identifying fluctuations that may signal neurodegenerative conditions, such as Parkinson's disease, e-Patram aspires facilitate early detection through noninvasive testing. The utilizes electrochemical methods attain high selectivity DA, even presence common interfering substances like ascorbic acid (AA) uric (UA), which often present urine can complicate due close value their redox potential with DA. By overcoming interference challenges modification electrode, provides reliable measurements comparable standard "catecholamine test." Extensive validation human samples confirms device's precision consistency, underscoring its practical tool routine both clinical everyday settings.
Язык: Английский
Процитировано
0Clinica Chimica Acta, Год журнала: 2024, Номер 566, С. 120039 - 120039
Опубликована: Ноя. 15, 2024
Язык: Английский
Процитировано
1